The Lynx Group

May 2016, Vol 7, No 4

The oncology National Practice Benchmark (NPB) annual report provides important information regarding oncology providers’ productivity, costs, practice revenues, and profits. Key findings from the 2015 report show that new patient visits and average drug spending are on the rise (Balch C, et al. J Oncol Pract. 2016;12:e437-e475).
Read Article


The realignment of incentives and enhanced collaboration in cancer research are priorities that would speed the pace of discovery, with the goal to “end cancer as we know,” said Vice President Joe Biden at the 2016 American Association for Cancer Research annual meeting. Mr Biden discussed aspects of the new “Moonshot” initiative to eliminate cancer, which was initiated by President Obama at his 2016 State of the Union Address.
Read Article

Anti–PD-1 treatment with the PD-1 inhibitor nivolumab (Opdivo) significantly improved survival in patients with head and neck squamous-cell carcinoma that progressed after platinum-based therapy, according to data from a phase 3 clinical trial known as CheckMate-141.
Read Article

Assessing quality care in the age of precision medicine can be challenging. In a special session at the 2016 Quality Care Symposium, various stakeholders presented their perspectives on the challenges and opportunities related to quality care in this rapidly changing landscape.
Read Article

Page 3 of 3


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: